Rishindra Mamidi Reddy, MD
To request an appointment call
Manage Your Profile
About
Rishindra M. Reddy, M.D., is the José José Alvarez Research Professor in Thoracic Surgery. He was born and raised in Michigan. He earned his undergraduate and medical degrees at Northwestern University, and completed his general surgery residency at Washington University-Barnes Jewish Hospital in St. Louis, Missouri. His spent two years during his residency, as a Clinical Research Fellow at the National Cancer Institute in Bethesda, Maryland. He completed his Thoracic Surgery residency at the University of Washington and was a visiting fellow at Memorial Sloan Kettering Cancer Center in New York. His academic interests include improving outcomes for patients with thoracic cancers, molecular targeting for thoracic cancers, resident and medical student education.
Clinical Specialization:
Dr. Reddy's clinical interests include all aspects of general thoracic surgery including thoracic oncology, minimally invasive techniques and robotics surgery, esophageal diseases, pectus repairs and therapy for end stage lung disease including transplantation and lung volume surgery.
Areas of Practice
General thoracic surgery, thoracic oncology, minimally invasive techniques, pectus repairs and therapy for end stage lung disease including transplantation and lung volume surgery.
Expertise
Locations
-
Thoracic Surgery Clinic | Taubman Center 1500 E Medical Center Dr
Floor 2 Reception C
Ann Arbor, MI 48109-5344Get Directions -
Medical Procedures Unit | University Hospital 1500 E Medical Center Dr
Floor 2
Ann Arbor, MI 48109-5051Get Directions -
Thoracic Surgery Clinic | Brighton Center for Specialty Care 7500 Challis Rd
Entrance 1, Level 1
Brighton, MI 48116-9416Get Directions
Insurance Accepted
University of Michigan Health participates with most health insurance plans.
Education & Training
Medical School or Training
Residency
Fellowships
Board Certifications
Professional Organizations
Research Overview
Dr. Reddy is currently working with Dr. Beer, of Thoracic Oncology, evaluating novel molecular pathways, currently Chk1, in lung cancer. He is also developing primary tumor xenografts of both lung and esophageal cancer. His goal is to develop this model with a translational goal of bringing new therapeutics to the clinic and improving lung and esophageal cancer outcomes. Other academic interests include teaching of residents and medical students and his participation at a national level to increase recruitment into cardiothoracic surgery.